Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion type Assertion NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_head.
- NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion description "[Use of CRC screening tests was significantly lower than mammography for breast cancer detection in women (20 vs. 82%, P<0.001) and use of serum prostate-specific antigen for prostate cancer detection in men (27 vs. 46%, P<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_provenance.
- NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion evidence source_evidence_literature NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_provenance.
- NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion SIO_000772 21989122 NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_provenance.
- NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion wasDerivedFrom befree-2016 NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_provenance.
- NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_assertion wasGeneratedBy ECO_0000203 NP930138.RAwQuVzgC8U9lHHnQ7_oPv7Wk-MBDsJ557KkeHnyOGJBg130_provenance.